Drusolv Therapeutics
Philadelphia, US · Founded 2017 · Pennsylvania corporation
Founders & leadership
JG
John G. EdwardsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2022
▶$500KraisedApr 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedApr 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John G. EdwardsExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $500K
- Proceeds to insiders
- $120K
- First sale
- Mar 2022
- Incorporated
- Corporation, Pennsylvania, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Drusolv Therapeutics raised?
- Drusolv Therapeutics has disclosed $500K raised across 1 round.
- Where is Drusolv Therapeutics headquartered?
- Drusolv Therapeutics is headquartered in Philadelphia, US.